[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:friedreich-ataxia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":92,"states":97},"Friedreich Ataxia",13,11,[8,16,23,29,36,42,48,54,60,66,72,78,85],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06953583","A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia",[12],"Phase 3","RECRUITING","2026-08-26T02:15:51.395565Z","2026-06-17T02:29:30.007283Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05302271","Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia",[20],"Phase 1","2026-08-26T02:17:05.172421Z","2026-05-05T02:43:29.512833Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07180355","A Study of SGT-212 Gene Therapy in Friedreich's Ataxia",[20],"2026-08-26T02:19:25.538428Z","2026-05-05T02:43:28.986929Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06447025","An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia",[33],"Phase 2","2026-08-26T02:18:08.005333Z","2026-05-05T02:43:27.066978Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06865482","Clinical Course Of Disease In Participants With FA-CM",[],"2026-08-26T02:16:01.910993Z","2026-05-13T02:55:06.586468Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06623890","A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors",[],"2026-08-26T02:18:24.494016Z","2026-05-13T02:55:06.557653Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06628687","A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and\u002For During Breastfeeding and About the Health of Their Babies",[],"2026-08-26T02:16:38.897933Z","2026-05-13T02:55:06.557162Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06016946","Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study",[],"2026-08-26T02:19:29.922117Z","2026-05-13T02:55:06.401303Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT02497534","Biomarkers in Friedreich's Ataxia",[],"2026-08-26T02:18:27.904411Z","2026-05-13T02:55:06.096069Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT02316314","Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)",[],"2026-08-26T02:19:26.493949Z","2026-05-13T02:55:06.092851Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT01793168","Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.077983Z",{"nct_id":79,"title":80,"phases":81,"status":82,"updated_at":83,"content_modified":84},"NCT07635030","GABA and GSH in FRDA",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:53.461103Z","2026-06-16T05:54:07.901428Z",{"nct_id":86,"title":87,"phases":88,"status":89,"updated_at":90,"content_modified":91},"NCT06054893","A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T02:07:10.948296Z","2026-05-05T02:43:29.338854Z",[93],{"biomarker":94,"count":95,"slug":96},"Frataxin, Mitochondrial",3,"frataxin-mitochondrial",[98,102,106,109],{"state":99,"count":100,"slug":101},"Pennsylvania",7,"pennsylvania",{"state":103,"count":104,"slug":105},"California",6,"california",{"state":107,"count":104,"slug":108},"Florida","florida",{"state":110,"count":111,"slug":112},"Ohio",4,"ohio"]